Accession Number: | 0001209191-20-035102 |
Date: | 2020-06-04 |
Issuer: | IGM BIOSCIENCES, INC. (IGMS) |
Original Submission Date: |
KEYT BRUCE
C/O IGM BIOSCIENCES, INC.
325 E. MIDDLEFIELD ROAD
MOUNTAIN VIEW, CA 94043
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-04 | M | 2,837 | a | $1.39 | 3,850 | indirect | ||
COMMON STOCK | 2020-06-04 | M | 150 | a | $40.27 | 4,000 | indirect | ||
COMMON STOCK | 2020-06-04 | F | 104 | d | $58.40 | 3,896 | indirect | ||
COMMON STOCK | 2020-06-04 | 0 | $0.00 | 2,637 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.39 | 2020-06-04 | deemed execution date | M | 2,837 (d) | 2029-02-01 | common stock 2,837 | $1.39 | 6,242 | indirect | see footnote | |
STOCK OPTION (RIGHT TO BUY) | 40.27 | 2020-06-04 | deemed execution date | M | 150 (d) | 2030-02-05 | common stock 150 | $40.27 | 2,250 | indirect | see footnote | |
STOCK OPTION (RIGHT TO BUY) | 1.39 | deemed execution date | 0 ( ) | 2029-02-01 | common stock 96,275 | $1.39 | 96,275 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 40.27 | deemed execution date | 0 ( ) | 2030-02-05 | common stock 75,000 | $40.27 | 75,000 | direct |
ID | footnote |
---|---|
f1 | the securities are held directly by the reporting person's spouse. |
f2 | the shares were withheld as payment of the exercise price in connection with option exercise. |
f3 | 1/48 of the shares subject to the option vest each month beginning on march 1, 2019. |
f4 | 1/48 of the shares subject to the option vest each month beginning on march 5, 2020. |